Results 191 to 200 of about 238,688 (339)

Assessment of the Effectiveness of Allergic Rhinitis Medications Using a Target Trial Emulation Approach Based on Mobile Health Data

open access: yes
Clinical &Experimental Allergy, EarlyView.
Nuno Lourenço‐Silva   +46 more
wiley   +1 more source

Quality of Dying Among Institutionalised Nursing Home Residents From the Caregivers' Perspective: A Mixed‐Methods Study

open access: yesJournal of Advanced Nursing, EarlyView.
ABSTRACT Aims To examine how family caregivers of deceased nursing home residents scored and justified their ratings for each item on the Quality of Dying in Long‐Term Care scale and to identify the consistencies and discrepancies between their perceptions and the scores assigned when assessing the residents' end‐of‐life experience. Design A convergent
Daniel Puente‐Fernandez   +5 more
wiley   +1 more source

Elevated neurofilament light levels in acute anorexia nervosa are associated with alterations in white matter volume and connectivity networks

open access: yesJournal of Child Psychology and Psychiatry, EarlyView.
Background Anorexia nervosa (AN) is a severe eating disorder associated with drastic reductions in gray and white matter (WM) volume and structural connectivity alterations. However, the hypotheses regarding underlying mechanisms are inconclusive. The current study investigated the relationships of WM volume as well as WM network architecture with ...
Inger Hellerhoff   +10 more
wiley   +1 more source

Paz

open access: yes
UIDB/00183/2020 UIDP/00183 ...
openaire   +1 more source

Long‐term safety and efficacy of secukinumab in paediatric severe plaque psoriasis: 236‐week, Phase 3 trial results

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
In this Phase III study, secukinumab demonstrated sustained efficacy and a favourable safety profile in paediatric patients with chronic severe plaque psoriasis over a treatment period of 236 weeks. Abstract Background Plaque psoriasis, a chronic inflammatory disease, affects up to 2.1% of the global paediatric population.
Andrzej Kaszuba   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy